Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bibuvit Plus
- Development stage
- Unknown
- Lead developer
- Sunlife
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Bibuvit Plus is a multi-ingredient nutritional supplement developed and marketed by Sunlife Pharmaceuticals. Formulated as a chocolate-coated tablet, it contains a synergistic blend of lycopene, biotin, ginkgo biloba, L-glutamic acid, green tea extract, grape seed extract, multivitamins, and multiminerals. The supplement is designed to support general health and wellness by providing potent antioxidant protection, promoting cardiovascular and cognitive health, and addressing daily nutritional deficiencies.
- Brand names
- Bibuvit Plus
- Other names
- Lycopene + Biotin + Ginkgo Biloba + L-Glutamic acid + Green Tea Extract + Grape Seed Extract + Multivitamins + Multiminerals
Beyond the preview
Go deeper on Bibuvit Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bibuvit Plus.